David K. Glover

David K. Glover has extensive work experience in various roles and industries. David is currently the Director of Research and Development at PBM Capital Group since April 2017. In 1985, they founded and managed Scientific Computing Solutions, LLC, where they developed custom software for biomedical research applications. David also co-founded Lewis & Clark Pharmaceuticals, Inc. in 2012 and served as a Co-Founder until December 2019. Furthermore, they were a Scientific Co-Founder at Adenosine Therapeutics, LLC from January 1992 to December 2019. Additionally, David worked as an Associate Professor of Medicine in Cardiovascular Medicine at the University of Virginia from September 1990 to June 2021. David also had research and teaching experience as an Instructor of Research at the University of Oklahoma from September 1986 to July 1990 and as an Electrical Engineer at Harvard University from January 1984 to July 1986. David'sareas of expertise include targeted radiolabeled probes for imaging cardiovascular diseases and cardioprotection.

David K. Glover holds a Ph.D. in Molecular Physiology & Cell Biophysics, which they obtained from the University of Virginia from 2000 to 2004. Prior to that, they earned a Master of Engineering in Biomedical Engineering from the same institution between 1981 and 1984. David began their academic journey at Randolph-Macon College, where they obtained a Bachelor of Science in Biology from 1977 to 1981.